News | July 26, 2022
Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Advancing to IND-enabling studies with multiple drug candidates
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
The drug will be manufactured at the group’s topical facility at Ahmedabad
Subscribe To Our Newsletter & Stay Updated
